Cancer treatment could be less effective if patients consume popular sweeteners
NEWNow you can listen to News articles!
A common artificial sweetener could make cancer treatments less effective, according to a new study.
The Sucralosa, a sweetener that is found in many diet soft drinks, low calorie and substitutes for powdered sugar, could interfere with immunotherapy in cancer patients, according to research from the University of Pittsburgh and the UPMC Hillman Cancer Center.
The study included 132 patients with melanoma (a deadly shape of skin cancer) and cell lung cancer I do not like (the most common type of lung cancer).
His daily dietary soda could be aging his brain faster than he believes, the study finds
All patients were taking anti-P1 (a type of immunotherapy), either alone or in combination with chemotherapy.
All completed dietary questionnaires that indicated the volume of artificial sweeteners they consumed.
Sucralose consumption could interfere with immunotherapy in cancer patients. (Istock)
The researchers found that patients who consumed high levels of Sucralosa had a “worst response” to immunotherapy and the “poorest survival” than those who consumed low quantities, according to a press release.
“We discovered that the Sucalosa prevented the effectiveness of immunotherapies in a variety of types of cancer, stages and treatment modalities,” said principal author Diwakar Davar, associate professor of Medicine at Pitt and a medical oncologist and hematologist at the UPMC Hillman Cancer Center, in the statement.
Sugar substitutes can cause brain changes that increase appetite, says the study
“These observations pose the possibility of designing prebiotics, such as supplementation with nutrients directed for patients who consume high levels of sucralose.”
The findings were published in Cancer Discovery, a magazine of the American Association for Cancer Research.
“It’s easy to say: ‘Stop drinking diet soft drinks’, but when patients are being treated by cancer, they are already dealing with enough.”
In a positive note, the researchers also found that taking supplements to increase the levels of amino acid arginine countered those effects and increased the effectiveness of immunotherapy, as seen in a study of mice.
“It is easy to say: ‘Stop drinking dietary soft drinks’, but when patients are being treated for cancer, they are already dealing with enough, so asking them to drastically alter their diet may not be realistic,” said principal author Abby Overacre, an assistant professor in the Department of Immunology in Pitt and UPMC Hillman Cancer Center, in the statement.
Sucralosa is a sweetener found in many diet sodas, low calorie snacks and powdered sugar substitutes. (Istock)
“We need to know the patients where they are. That is why it is so exciting that arginine supplementation could be a simple approach to counteract the negative effects of sucralose on immunotherapy.”
In the study of the mouse, it was shown that the succalose alters the intestinal microbiome in a way that reduced arginine levels. This amino acid is essential for the T cell function, which is a key component of immunotherapy medications.
Click here to get the News application
“When arginine levels were exhausted due to changes driven by the sugar in the microbioma, T cells could not work properly,” said Ovear. “As a result, immunotherapy was not so effective in mice that were fed with sucral.”
“For people who undergo cancer treatment, all orientation must come from their medical care team.”
Looking to the future, researchers plan to launch a clinical trial that investigates arginine supplementation in patients with human cancer. They will also explore the potential impact of other sugar substitutes on the effectiveness of immunotherapy.
The study was supported by the National Health Institutes, the Damon Runyon Cancer Research Foundation and Gateway for Cancer Research.
Click here to register in our health newsletter
The heat control Council provided the following statement to News Digital.
“For people who undergo cancer treatment, all orientation must come from their medical care team,” said Carla Saunders, president of the Council.
The researchers found that patients who consumed high levels of Sucralosa had a “worst response” to immunotherapy and the “poorest survival” than those who consumed low quantities. (Istock)
“This study has several limitations, depending on animal research that cannot be applied directly to humans, and [is] A small observation study in humans that use self -informed dietary data, which is often subject to bad reports, sub -registration and bias. While continuous research is critical, the scientific regulatory authorities worldwide, including FDA, have repeatedly confirmed the safety of the succalose for decades. “
For more health articles, visit www.Newsnews.com/health
News Digital communicated with the manufacturers of products that contain succalose that requested comments.
Melissa Rudy is a senior health editor and a member of the lifestyle in News Digital. The advice of history can be sent to melissa.rudy@News.com.